Long-term follow up of infliximab therapy in inflammatory arthritis

Indian Journal of Rheumatology

Volumn 2, Issue 1, 2007, Pages 8-10

  Narayanan, K ^a   Anand, K P ^b  

^a ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

^b Dept of Plastic Surgery   (India)

Author keywords

Arthritis; Infliximab; Long term; Therapy; Tuberculosis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HEADACHE; HEPATITIS B; HERPES ZOSTER; HUMAN; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SUPERINFECTION; TINEA VERSICOLOR; TOTAL HIP PROSTHESIS; TUBERCULOSIS;

EID: 84992260359     PISSN: 09733698     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0973-3698(10)60021-0     Document Type: Article

References (8)

1. Brennan FM, Feldman M. Cytokines in autoimmunity. Curr Opin Immunol 1992; 4: 754-9.
2. Maini RN, Breedveld FC, et al. Therapeutic efficacy of multiple intravenous infusions of anti tumour necrosis factor-α monoclonal antibody combined with low dose weekly methotrexate in Rheumatoid arthritis. Arthritis Rheum 1998; 41: 1552-63.
3. Braun J, Bellow M, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38: 499-505.
4. Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, et al. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing apondylitis. Ann Rheum Dis 2005; 64: 229-34.
5. Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005; 64: 1150-7.
6. Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections inpatients with rheumatoid arthritis under anti TNF-α therapy. Rheumatology (Oxford) 2003; 42: 617-21.
7. Grover R, Kapoor S, Marwaha V, Malaviya AN, Gupta R, Kumar A. Clinical experience with infliximab in spondyloarthropathy: an open label study on fourteen patients. JIRA 2005; 13: 78-82.
8. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM, et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with TNF antagonists. Arthritis Rheum 2005; 52: 1766-72.